Can IGF-I polymorphism affect power and endurance athletic performance?

Growth Hormone and IGF Research

Volumn 23, Issue 5, 2013, Pages 175-178

  Ben Zaken, Sigal ^a   Meckel, Yoav ^a   Nemet, Dan ^b   Eliakim, Alon ^b  

^a The Zinman College of Physical Education and Sports Sciences at the Wingate Institute   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Athletic performance; Endurance athletes; Genetic polymorphism; IGF1; Power athletes

Indexed keywords

GENOMIC DNA; SOMATOMEDIN C;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; CONTROLLED STUDY; ENDURANCE SPORT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN LIKE GROWTH FACTOR I GENE; ISRAEL; MALE; MUSCLE MASS; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POWER SPORT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPORT;

ATHLETIC PERFORMANCE; ENDURANCE ATHLETES; GENETIC POLYMORPHISM; IGF1; POWER ATHLETES;

ADULT; ATHLETES; ATHLETIC PERFORMANCE; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISRAEL; MALE; MIDDLE AGED; MUSCLE STRENGTH; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84882830933     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.06.005     Document Type: Article

References (41)

1. Coleman M.E., DeMayo F., Yin K.C., et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 1995, 270(20):12109-12116.
2. Powell-Braxton L., Hollingshead P., Warburton C., et al. IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993, 7(12B):2609-2617.
3. Gonzalez E., Messi M.L., Zheng Z., Delbono O. Insulin-like growth factor-1 prevents age-related decrease in specific force and intracellular Ca2+ in single intact muscle fibres from transgenic mice. J. Physiol. 2003, 552(Pt 3):833-844.
4. Greig C.A., Hameed M., Young A., Goldspink G., Noble B. Skeletal muscle IGF-I isoform expression in healthy women after isometric exercise. Growth Horm. IGF Res. 2006, 16(5-6):373-376.
5. Bamman M.M., Petrella J.K., Kim J., Mayhew D.L., Cross J.M. Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans. J. Appl. Physiol. 2007, 102(6):2232-2239.
6. Eliakim A., Nemet D. Exercise training, physical fitness and the growth hormone-insulin-like growth factor-1 axis and cytokine balance. Med. Sport Sci. 2010, 55:128-140.
7. Nemet D., Eliakim A. Growth hormone-insulin-like growth factor-1 and inflammatory response to a single exercise bout in children and adolescents. Med. Sport Sci. 2010, 55:141-155.
8. Eliakim A., Brasel J.A., Mohan S., Barstow T.J., Berman N., Cooper D.M. Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J. Clin. Endocrinol. Metab. 1996, 81(11):3986-3992.
9. Eliakim A., Scheett T.P., Newcomb R., Mohan S., Cooper D.M. Fitness, training, and the growth hormone-insulin-like growth factor I axis in prepubertal girls. J. Clin. Endocrinol. Metab. 2001, 86(6):2797-2802.
10. Courteix D., Rieth N., Thomas T., et al. Preserved bone health in adolescent elite rhythmic gymnasts despite hypoleptinemia. Horm. Res. 2007, 68(1):20-27.
11. Ahtiainen M., Pöllänen E., Ronkainen P.H.A., et al. Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women. Age (Dordr.) 2012, 34(5):1249-1260.
12. Poehlman E.T., Copeland K.C. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J. Clin. Endocrinol. Metab. 1990, 71(6):1468-1473.
13. Doessing S., Kjaer M. Growth hormone and connective tissue in exercise. Scand. J. Med. Sci. Sports 2005, 15(4):202-210.
14. Doessing S., Heinemeier K.M., Holm L., et al. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J. Physiol. 2010, 588(Pt 2):341-351.
15. Heinemeier K.M., Mackey A.L., Doessing S., et al. GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans. Scand. J. Med. Sci. Sports 2012, 22(4):e1-e7.
16. Höppener J.W., De Pagter-Holthuizen P., Geurts van Kessel A.H., et al. The human gene encoding insulin-like growth factor I is located on chromosome 12. Hum. Genet. 1985, 69(2):157-160.
17. Wong H.-L., Delellis K., Probst-Hensch N., et al. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol., Biomarkers Prev. 2005, 14(1):144-151.
18. Zhai G., Rivadeneira F., Houwing-Duistermaat J.J., et al. Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study. Ann. Rheum. Dis. 2004, 63(5):544-548.
19. Rivadeneira F., Houwing-Duistermaat J.J., Beck T.J., et al. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J. Bone Miner. Res. 2004, 19(8):1280-1290.
20. Bleumink G.S., Schut A.F.C., Sturkenboom M.C.J.M., et al. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy. Heart 2005, 91(2):239-240.
21. Vaessen N., Heutink P., Janssen J.A., et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001, 50(3):637-642.
22. Fletcher O., Gibson L., Johnson N., et al. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol., Biomarkers Prev. 2005, 14(1):2-19.
23. Hernandez W., Grenade C., Santos E.R., Bonilla C., Ahaghotu C., Kittles R.A. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 2007, 28(10):2154-2159.
24. Canzian F., McKay J.D., Cleveland R.J., et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br. J. Cancer 2006, 94(2):299-307.
25. Patel A.V., Cheng I., Canzian F., et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 2008, 3(7):e2578.
26. Palles C., Johnson N., Coupland B., et al. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum. Mol. Genet. 2008, 17(10):1457-1464.
27. Cheng I., Stram D.O., Penney K.L., et al. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J. Natl. Cancer Inst. 2006, 98(2):123-134.
28. Zebrowska A., Gasior Z., Langfort J. Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy. J. Sports Sci. Med. 2009, 8:67-76.
29. Zebrowska A., Waśkiewicz Z., Zajac A., Gasior Z., Galbo H., Langfort J. IGF-1 response to arm exercise with eccentric and concentric muscle contractions in resistance-trained athletes with left ventricular hypertrophy. Int. J. Sports Med. 2012, 34(2):116-122.
30. Kostek M.C., Delmonico M.J., Reichel J.B., et al. Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults. J. Appl. Physiol. 2005, 98(6):2147-2154. (Available at: http://www.ncbi.nlm.nih.gov/pubmed/15894537, Accessed October 26, 2012).
31. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab. 1998, 83(7):2286-2290.
32. Okada Y., Kamatani Y., Takahashi A., et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum. Mol. Genet. 2010, 19(11):2303-2312.
33. Kostek M.C., Devaney J.M., Gordish-Dressman H., et al. A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study. Eur. J. Appl. Physiol. 2010, 110(2):315-324.
34. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
35. Lynch N.A., Metter E.J., Lindle R.S., et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J. Appl. Physiol. 1999, 86(1):188-194. (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9887130, Accessed December 21, 2012).
36. Reed R.L., Pearlmutter L., Yochum K., Meredith K.E., Mooradian A.D. The relationship between muscle mass and muscle strength in the elderly. J. Am. Geriatr. Soc. 1991, 39(6):555-561.
37. Lord S.R., Ward J.A., Williams P., Anstey K.J. Physiological factors associated with falls in older community-dwelling women. J. Am. Geriatr. Soc. 1994, 42(10):1110-1117.
38. Rantanen T., Era P., Heikkinen E. Physical activity and the changes in maximal isometric strength in men and women from the age of 75 to 80years. J. Am. Geriatr. Soc. 1997, 45(12):1439-1445.
39. Chagnon Y.C., Rice T., Pérusse L., et al. Genomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE. J. Appl. Physiol. 2001, 90(5):1777-1787.
40. Sun G., Gagnon J., Chagnon Y.C., et al. Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int. J. Obes. Relat. Metab. Disord. 1999, 23(9):929-935.
41. Krych-Garsztka K., Mizgajska-Wiktor H., Gozdzucka-Jojefiak A. An analysis of the regulatory region of the IGF1 gene in professional athletes in youth sports teams. Hum. Mov. 2011, 12(3):216-222.